<SEC-DOCUMENT>0001193125-24-135296.txt : 20240509
<SEC-HEADER>0001193125-24-135296.hdr.sgml : 20240509
<ACCEPTANCE-DATETIME>20240509161918
ACCESSION NUMBER:		0001193125-24-135296
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20240509
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240509
DATE AS OF CHANGE:		20240509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		24931007

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d802416d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20240509" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-05-09_to_2024-05-09">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-334">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-05-09_to_2024-05-09">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cvs-20240509.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-05-09_to_2024-05-09"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-09</xbrli:startDate> <xbrli:endDate>2024-05-09</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-345">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt:datemonthdayyearen" id="ixv-346">May&#160;9, 2024</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g802416g0509101857252.jpg" alt="LOGO"/></p> <p style="margin-top:1pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:stateprovnameen" id="ixv-347">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-348">001-01011</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-349">05-0494040</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-350">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-351">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:stateprovnameen" id="ixv-352">Rhode Island</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-353">02895</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-354">(401)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-355">765-1500</ix:nonNumeric></span></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report: N/A</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:boolballotbox" id="ixv-356">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:boolballotbox" id="ixv-357">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:boolballotbox" id="ixv-358">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:boolballotbox" id="ixv-359">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-360">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-361">CVS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:exchnameen" id="ixv-362">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-05-09_to_2024-05-09" format="ixt-sec:boolballotbox" id="ixv-363">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;8 - Other Events </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;9, 2024, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221;), issued and sold $1,000,000,000 aggregate principal amount of the Company&#8217;s 5.400% Senior Notes due 2029 (the &#8220;2029 Notes&#8221;), $1,000,000,000 aggregate principal amount of the Company&#8217;s 5.550% Senior Notes due 2031 (the &#8220;2031 Notes&#8221;), $1,250,000,000 aggregate principal amount of the Company&#8217;s 5.700% Senior Notes due 2034 (the &#8220;2034 Notes&#8221;), $750,000,000 aggregate principal amount of the Company&#8217;s 6.000% Senior Notes due 2044 (the &#8220;2044 Notes&#8221;), and $1,000,000,000 aggregate principal amount of the Company&#8217;s 6.050% Senior Notes due 2054 (the &#8220;2054 Notes&#8221; and, together with the 2029 Notes, the 2031 Notes, the 2034 Notes and the 2044 Notes, the &#8220;Notes&#8221;). The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File <span style="white-space:nowrap">No.&#160;333-272200,</span> dated May&#160;25, 2023 (the &#8220;Registration Statement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are governed by and issued pursuant to a Senior Indenture dated August&#160;15, 2006 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#8220;Senior Indenture&#8221;). The Company may issue additional senior debt securities from time to time pursuant to the Senior Indenture. The form of Senior Indenture was filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed on August&#160;15, 2006 and shall be incorporated by reference into this Current Report on Form <span style="white-space:nowrap">8-K.</span> The forms of the Notes are filed as Exhibits 4.1, 4.2, 4.3, 4.4 and 4.5 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated by reference into the Registration Statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Section</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;9</span>&#160;&#8211;<span style="font-weight:bold">&#160;Financial Statements and Exhibits</span> </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Exhibits</span>. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> are as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INDEX TO EXHIBITS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802416dex41.htm">Form of the 2029 Note.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802416dex42.htm">Form of the 2031 Note.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802416dex43.htm">Form of the 2034 Note.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802416dex44.htm">Form of the 2044 Note.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802416dex45.htm">Form of the 2054 Note.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802416dex51.htm">Opinion of Allen Overy Shearman Sterling US LLP.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d802416dex51.htm">Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="font-weight:bold">CVS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: May&#160;9, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Thomas F. Cowhey</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Thomas F. Cowhey</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Executive Vice President and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d802416dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 4.1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EB2 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EB25 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.400% Senior Note due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2029. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2029 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May 9, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2029 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.400% Senior Note due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.400% Senior Notes due 2029 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2024.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from May&nbsp;9, 2024. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,000,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means May&nbsp;1, 2029 (one month prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 15 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily) -&#8201;H.15&#148; (or any successor designation or publication)
(&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall select, as
applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant
maturity on H.15 exactly </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant
maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or
(3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable
Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity
that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant
from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date
preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company
shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00
a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the
depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No Notes of
a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new Note in a
principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the redemption
of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or
the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of
Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes
may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a
majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it
determines that withholding such notice is in the interest of the Holders of Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d802416dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 4.2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EC0 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EC08 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.550% Senior Note due 2031 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2031. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2031 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May 9, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to in the Indenture. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2031 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.550% Senior Note due 2031 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.550% Senior Notes due 2031 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2024.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from May 9, 2024. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,000,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means April&nbsp;1, 2031 (two months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 20 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or publication)
(&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall select, as
applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant
maturity on H.15 exactly </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant
maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or
(3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable
Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity
that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant
from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date
preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company
shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00
a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the
depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No Notes of
a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new Note in a
principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the redemption
of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or
the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of
Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes
may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a
majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it
determines that withholding such notice is in the interest of the Holders of Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your Signature: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>d802416dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 4.3 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 ED8 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650ED80 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.700% Senior Note due 2034 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2034. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2034 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May 9, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2034 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.700% Senior Note due 2034 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.700% Senior Notes due 2034 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2024.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from May 9, 2024. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,250,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means March&nbsp;1, 2034 (three months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 20 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily) -&#8201;H.15&#148; (or any successor designation or publication)
(&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall select, as
applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant
maturity on H.15 exactly </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant
maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or
(3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable
Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity
that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant
from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date
preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company
shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00
a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the
depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No Notes of
a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new Note in a
principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the redemption
of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or
the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of
Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes
may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a
majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it
determines that withholding such notice is in the interest of the Holders of Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Date: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Your Signature: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>5
<FILENAME>d802416dex44.htm
<DESCRIPTION>EX-4.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 4.4 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EE6 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EE63 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.000% Senior Note due 2044 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2044. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2044 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May 9, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2044 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.000% Senior Note due 2044 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 6.000% Senior Notes due 2044 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2024.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from May 9, 2024. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$750,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means December&nbsp;1, 2043 (six months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 25 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or publication)
(&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall select, as
applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant
maturity on H.15 exactly </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant
maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or
(3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable
Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity
that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant
from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date
preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company
shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00
a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the
depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No Notes of
a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new Note in a
principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the redemption
of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or
the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of
Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes
may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a
majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it
determines that withholding such notice is in the interest of the Holders of Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your Signature: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>6
<FILENAME>d802416dex45.htm
<DESCRIPTION>EX-4.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 4.5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EF3 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EF39 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.050% Senior Note due 2054 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on June&nbsp;1, 2054. If such maturity date is not a Business Day, then payment of
principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: June&nbsp;1 and December 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each May&nbsp;15 and November&nbsp;15, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2054 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May 9, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [ ] of 2054 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.050% Senior Note due 2054 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 6.050% Senior Notes due 2054 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on June&nbsp;1 and December&nbsp;1 of each year, commencing December&nbsp;1, 2024.
Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from May 9, 2024. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the May&nbsp;15 and November&nbsp;15 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,000,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time,
at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest thereon
discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at
a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Par Call Date</B>&#148; means December&nbsp;1, 2053 (six months prior to the maturity date of the Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Spread</B>&#148; means 25 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or publication)
(&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall select, as
applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant
maturity on H.15 exactly </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant
maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or
(3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable
Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity
that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant
from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with a maturity date
preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company
shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00
a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the
depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of DTC. No Notes of
a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed. A new Note in a
principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary), the redemption
of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption
date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Repurchase of the Notes Upon a Change of
Control Triggering Event </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to
require the Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in
this Note. In the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but
excluding, the date of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or
transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed
(the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of
Control Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of the
Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or
the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Amendment; Waiver </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Defaults and Remedies </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of
Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes
may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a
majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it
determines that withholding such notice is in the interest of the Holders of Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:22%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your Signature: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>7
<FILENAME>d802416dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g802416dsp70.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">599 Lexington Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10022-6069 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">+1.212.848.4000 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">May&nbsp;9, 2024
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One CVS Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Woonsocket, RI 02895 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,000,000,000 5.400% Senior Notes due 2029 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,000,000,000 5.550% Senior Notes due 2031 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,250,000,000 5.700% Senior Notes due 2034 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$750,000,000 6.000% Senior Notes due 2044 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,000,000,000 6.050% Senior Notes due 2054 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to CVS Health
Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), in connection with the issuance and sale by the Company of $1,000,000,000 aggregate principal amount of the Company&#146;s 5.400% Senior Notes due 2029 (the
&#147;<U>20</U><U>29</U><U> Notes</U>&#148;), $1,000,000,000 aggregate principal amount of the Company&#146;s 5.550% Senior Notes due 2031 (the &#147;<U>20</U><U>31</U><U> Notes</U>&#148;), $1,250,000,000 aggregate principal amount of the
Company&#146;s 5.700% Senior Notes due 2034 (the &#147;<U>20</U><U>34</U><U> Notes</U>&#148;), $750,000,000 aggregate principal amount of the Company&#146;s 6.000% Senior Notes due 2044 (the &#147;<U>2044 Notes</U>&#148;), and $1,000,000,000
aggregate principal amount of the Company&#146;s 6.050% Senior Notes due 2054 (the &#147;<U>20</U><U>54</U><U> Notes</U>&#148; and, together with the 2029 Notes, the 2031 Notes, 2034 Notes and the 2044 Notes, the &#147;<U>Notes</U>&#148;), pursuant
to the Underwriting Agreement, dated May&nbsp;7, 2024 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company and the underwriters named therein. The Notes will be issued pursuant to an indenture, dated as of August&nbsp;15, 2006 (the
&#147;<U>Indenture</U>&#148;), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#147;<U>Trustee</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
that connection, we have reviewed originals or copies of the following documents: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Underwriting Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Executive Officers&#146; Certificate pursuant to the Indenture dated May&nbsp;9, 2024; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Notes in global form as executed by the Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>AOSHEARMAN.COM </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Allen Overy Shearman Sterling US LLP is a
limited liability partnership organized under the laws of the State of Delaware. Allen Overy Shearman Sterling US LLP is affiliated with Allen Overy Shearman Sterling LLP, a limited liability partnership registered in England and Wales with
registered number OC306763 and with its registered office at One Bishops Square, London E1 6AD. It is authorized and regulated by the Solicitors Regulation Authority of England and Wales (SRA number&nbsp;401323). The term partner is used to refer to
a member of Allen Overy Shearman Sterling LLP or an employee or consultant with equivalent standing and qualifications. A list of the members of Allen Overy Shearman Sterling LLP and of the <FONT STYLE="white-space:nowrap">non-members</FONT> who are
designated as partners is open to inspection at its registered office at One Bishops Square, London E1 6AD. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The documents described in the foregoing clauses (a)&nbsp;through (d) are collectively referred to herein as
the &#147;<U>Opinion Documents</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our review of the Opinion Documents, we have assumed: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The genuineness of all signatures. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The authenticity of the originals of the documents submitted to us. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The conformity to authentic originals of any documents submitted to us as copies. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As to matters of fact, the truthfulness of the representations made in the Underwriting Agreement and the other
Opinion Documents and in certificates of public officials and officers of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That each of the Opinion Documents is the legal, valid and binding obligation of each party thereto, other than
the Company, enforceable against each such party in accordance with its terms. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not, except with respect to Generally Applicable Law, violate any law, rule or regulation applicable to it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not result in any conflict with or breach of any agreement or document binding on it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, except with respect to Generally Applicable Law, no authorization, approval, consent or other action by,
and no notice to or filing with, any governmental authority or regulatory body or any other third party is required for the due execution, delivery or performance by the Company of any Opinion Document to which it is a party or, if any such
authorization, approval, consent, action, notice or filing is required, it has been duly obtained, taken, given or made and is in full force and effect. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not independently established the validity of the foregoing assumptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Generally Applicable Law</U>&#148; means the federal law of the United States of America, and the law of the State of New&nbsp;York (including in
each case the rules or regulations promulgated thereunder or pursuant thereto), that a New&nbsp;York lawyer exercising customary professional diligence would reasonably be expected to recognize as being applicable to the Company, the Opinion
Documents or the transactions governed by the Opinion Documents, and for purposes of assumption paragraphs (f)&nbsp;and (h) above and our opinion below, the General Corporation Law of the State of Delaware. Without limiting the generality of the
foregoing definition of Generally Applicable Law, the term &#147;Generally Applicable Law&#148; does not include any law, rule or regulation that is applicable to the Company, the Opinion Documents or such transactions solely because such law, rule
or regulation is part of a regulatory regime applicable to any party to any of the Opinion Documents or any of its affiliates due to the specific assets or business of such party or such affiliate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and upon such other investigation as we have deemed necessary and subject to the
qualifications set forth below, we are of the opinion that the Notes have been duly authorized and executed by the Company and, when authenticated by the Trustee in accordance with the Indenture and delivered and paid for as provided in the
Underwriting Agreement, the Notes will be the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms and entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion expressed above is subject to the following qualifications: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is subject to the effect of any applicable bankruptcy, insolvency, reorganization, moratorium
or similar laws affecting creditors&#146; rights generally (including without limitation all laws relating to fraudulent transfers). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is also subject to the effect of general principles of equity, including without limitation
concepts of materiality, reasonableness, good faith and fair dealing (regardless of whether considered in a proceeding in equity or at law). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion is limited to Generally Applicable Law, and we do not express any opinion herein concerning any
other law. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter speaks only as of the date hereof. We expressly disclaim any responsibility to advise you of any
development or circumstance of any kind, including any change of law or fact, that may occur after the date of this opinion letter and which might affect the opinions expressed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter is rendered to you in connection with the transactions contemplated by the Opinion Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed
May&nbsp;9, 2024 by the Company and incorporated by reference into the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3ASR</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-272200)</FONT> filed by the Company to effect
the registration of the Notes under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), and to the use of our name under the heading &#147;Legal Matters&#148; in the prospectus constituting a part of such Registration
Statement. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Allen Overy Shearman
Sterling US LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LN/eb/ss/dh </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RA </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cvs-20240509.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/9/2024 11:23:53 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:cvs="http://www.cvshealth.com/20240509"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20240509"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20240509_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20240509_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cvs-20240509_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/9/2024 11:23:54 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cvs-20240509_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/9/2024 11:23:54 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20240509.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g802416dsp70.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g802416dsp70.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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;0!^E 6L(+:!;@SB&,3$8,@4;B/K0%B6@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g802416g0509101857252.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g802416g0509101857252.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  3 &@# 2(  A$! Q$!_\0
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M?W:AADX)&[)!YZ#BL&UT/5M(T3PC8W>D7EXUOJK7MPD,8D6",I(H4Y.,Y<'
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,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140399631512080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 09, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY7P O)E6;S(-FW.(:SY/,;3:[1ENU_]'FRECP6[_E-G!>=JB2/W^91=CJU<
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M/UY_ 5!+ 0(4 Q0    ( &6"J5@'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 98*I6%V\> KN
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ 98*I6)E<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " !E@JE8:3L:"SX$  "!$   &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ 98*I6)^@&_"Q @  X@P   T              ( !@0P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !E@JE8EXJ[',     3 @  "P
M    @ %=#P  7W)E;',O+G)E;'-02P$"% ,4    " !E@JE8'#AEZC\!   \
M @  #P              @ %&$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ 98*I6"0>FZ*M    ^ $  !H              ( !LA$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 98*I6&60>9(9 0  SP,
M !,              ( !EQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  X1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d802416d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d802416d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File>cvs-20240509.xsd</File>
    <File>cvs-20240509_lab.xml</File>
    <File>cvs-20240509_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d802416d8k.htm">d802416d8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g802416g0509101857252.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d802416d8k.htm": {
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20240509",
   "dts": {
    "schema": {
     "local": [
      "cvs-20240509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20240509_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20240509_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d802416d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-05-09_to_2024-05-09",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d802416d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-05-09_to_2024-05-09",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d802416d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cvshealth.com//20240509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001193125-24-135296-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-135296-xbrl.zip
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MUK,7QO)"D%:"K!32:WPMVK"\R%?72_'$E3XR?W<B.T73O[Z@S_P'4$L#!!0
M   ( &6"J5CH%SFVM@0  'TJ   4    8W9S+3(P,C0P-3 Y7W!R92YX;6S5
MFEV/XC84AN]7VO_@IC>MU! ",VU!PZXH,U.AS@<"MJUZLS+) :PZ-K+- /^^
MQP%7!,(4IMLJYH(/Q^_QZ_,XCF-R\W&=<?("2C,I.D%<JP<$1")3)F:=8*E#
MJA/& J(-%2GE4D GV( ./GYX_^[FJS DM_?])Q*2N3$+W8ZBU6I52Z=,:,F7
M!D/J6B*SB(2AJ]\;?R*_;IMKDR%PH!I(1K4!17Y:,IZV&_5&,Z['C5IC7Z:
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MA<\NG A178*OVG8@_X>MD)OH*#4/6& ?F]P>L6_V(4 L^0M02P,$%     @
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M7D@)!EO2]C2MW,ORIJ# DA??;(%*K7:D32=70;*7XM(.,;W3^I2"@D*Q1CW
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M;,K,L0\2!:]!Y3-Q]CVSPRG0F""1SV(D6;,HO2P.?I"PUSQ,]\N'HJ%?7@E
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MC><P44K8D/U0$=)HF2H)XJ$8 <+*P ?$X5/TMP$7EH2PU9^>6EMFB=<:E#.
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MYN'0N"2"\I,"\B4(V90DOQC]^:##)E]39I*:[:XO04>,,,_(RT_V#OO4O@T
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M0O:/:U1-R/NSF"EK1)ED7K2Z:MC()>%\G:'X;S!P!G"8__GTH+:B5"79$HS
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ML_EBY_2;HAU'+TZNSC[#E^>]RXOC_P%02P,$%     @ 98*I6.5*3&!-*
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M,]$ UYE8"Y.! B()9P.452A\TTRR,"\DJ2&!\Q.DQDUEDIEAW$/ *<G@!&/
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M&ZAU9131('S1R9UZ@-7PD8?0OXJQ?K^J^FB]K#G\9LW%2#5-<YIVK")1)L-
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M7\.J:"L0L/VQ9JH.[-LI>8O..*D6&=X9#)7$(>@LP0@,9Y31C;M-U$D@ZW2
MB95P[4B7<]A38#A51=P'-0M4"2_'SRV9]M*E&J*3C%+"$K39M<3TLG$2ASF=
M9D.%;,BV=P+.0Q]AV&$"A!=,0S[UG%X&',WP2\NTEK5*!BXP10DP6SJ3D75(
MQ4/,\!DHD_Y(2RSDJRYCZ1K?\I(SK3>%E'/7+BV(T-*WO=&T\%TQ7M[B=$*/
M\$9J+ -KJQ:PG6(Z]H/B!S8H?D_*G4W)=+A_."[NBBYRY](;HF9"YI6M0LS<
M.$[L3C^$7ET[E,M^_032 %;\4NM?SHA'9#U,QP\CETL?C(H 7RREL&HJ,<HX
MZ9M2ZTD);+3[K,M-R <89#.M0*QQVLAQ@;NLG=_>\?"8H9=$[$I(C!9 \-=T
MM2$]8U8;H6*:A('Q]1I<ZE*U4%JGL-%RK:N&YT+32^.'RLQ00:]LK;F;A=P$
MT R*9]$3[79C*"YI*U3)2#)'U52PE-434$$25CN&"Z='Z$%M"E5[%JY1MGCP
M2NT>F%PB&VBL;#6^ZEH)3 8G48<%#*3_>*Z 4,ZUEU^-9J'T))@>BI<.G)P*
MI"C-N?0=U+<\RQT/?QQ%6DWWEE@NB,@ U[&%>#W.#P@MP,:)5*B[^JTBR3U6
M6##W8+6P Z1# #QS<"Y/7^P_:5.('CJWQ5WVD/30/N!G&A)MO.48 6I_F'O'
MJ:Y^$K2+-Z^]$*3DNR#)9LIZ,0Q:&!!:1^ T7X#XZ969ZX*$<@J+?XKOWY1:
M@:AA(<-9B-\>%=?C8'OSS;U@?FPC<J];3+&I3+'IC*_=FT8C9 >(/\2J5B/;
MA48OKW\K:P^B?WP)5D-9LV^V!KAS<<EK!X772B;P!UINX)+[5:-7Y#='K Y#
MK]M%!90-K+WU:RU1 ]1J6A)/50+'FBLR44$I"(L52M1[D6\ 8YJGE+<@>J:Z
M_V]4IQV 3EP4"B5+W3&K=1H0PR:3#T6AI5_4!ZW!:A7():KF'(1RBGUFD\\$
M2P1+WFY![KI9:KLG6R>X7Z*H?#/!4AMS6GI4%QAQ=#)"E@FJ<Y*R,QR$/3=_
MZY.VC_F")I]E#6O2=]'8+SG[VMJ(>P_3^M.WE 'E#V\I*!B#7U2IEDQ"Q@7"
MR!5B"ZK6<JB@':W3+M#-L:"Y4EWG'VD;W^1O2E#QDYK?MX"511?U($,@KSDN
MV3H4!3)#D[N>TSU=]P!3NN7#Y6R)]%[); I/<>Y!(N>15H^I= >G),>'*3(K
MT1WQ9=\/I#WZJ;#Y3=CY1J.:YPO(J #ZG'FA[OM-3\2 NC-W,VA?9EEI7DU;
M<9R<9KR>9DL*CL_5<\X*OK][#*UGK_6/.MS+^6345$>-8NN-<IXC<FL&9>;U
MT0:K!T[) ]F,[E2:$2%]3/#$MID;$\4L%3\8V]ROM::<;'9G4K%^^7C ""A8
MJ7'%WU:V4!VBD$N9^S>B(\JY-#D'D8F,<;^4R(OP^M6>QC<V"P?&)1&4GQ20
M+T'(IB3YQ>C/!QTV^:(RD]5L=WT).F*$>49>?K)WV*?V;0#82!=9Q9B74 BK
M)=(6O=F-#(RK@8%&61Y%(';[:L"%<IB33QX@,J/B- W0[S&(Y]$HT7Q>]]5P
MNRO,YE9!XA\W3TP7,6SB6!/PQ3B>X_T>_)E+#L0:5.D))9D$J:8NY_/0L69,
M!:2(S8Q]5ZA"\RCWN&(L\R\HW/Z0)1O&8FV6E@R-L>=U%C4LX2B.<=!L#W+X
MJFG"5-@ %/U>:L<20FS3.'*!>K/.Z?!X^)ZB"VP0<]LH32*N<B*D=-1AD$S(
M, DB6-0DIS5BG1YZRI <,U]"FS0)6UM S[LF0/^:<=&<Z<9F5S$W9$TG?$4E
MH'8?:K$,&FZ0]&<3S!/L<[,ZH"-%)Q\U&$U4>5]F30_HJ**8-5SFS2JVVEKU
MAMW2O :2;R.%?Z]!2ALMH%M:48D,65)G'>>P[-.K/'$[Q\JFH>1A$&I&QID]
M:!4P&P,V:_<*N!?9,AU=W2P.7IZOU:#GX-6Y\\<7O4(YISR60(<Q,R(5P>GI
M8Z(+\$:P>,;!%"'41;38B-3D'^8[!AA*Q_:0F#^1Q=@."[L$QK,,"972K.*R
M(:QV;<:XBXD8IL!>$W.@RA\IG^:]JYXA+@3Z?3]C\M=_8YN%FFU<@$TM@2 7
M4C,#5FL!*^0"H:92GJ:+S<PD;3BU1&"+T_9*P-(K.L34 9;ZL]B.KYP[,\A'
MP&K&(5+LG,!?EB*9;0O.WR]%C^ZU8*P5_5%WB/#:VN3:4F1@7T7,-9@#8225
M5T&[-=4M_GQ5I]C]INK;!+X!@VB-%&6U%+M4<+W32V_'@ .G7,B'#)(X.Z8(
M_S/VTS,GU!2PV&C%8, 6Z)W3CM/5? E%_>A@:X/(_K@!E@.:"UJ"]FP45'"9
MBYN6B_P@NHO#NW(#'"1IKO;-;$1/]6.RCMVY0$FG/\RI;]AN3'W#["8M6(?
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MI,!WDY'2]UL-04LE^?3DT#C"M'V;L;5*H$,!A=VWW3])Z&IW#A[^"<<6.$!
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M*!Q'$N V !PE,J7PQ4=Z+4FM./X VY.26I6I%"SG_@+>GC::1E#FDQ#>+(2
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M$ ,?L !B&FD2Z[2@D8I@F1BI0'/<)3U0U&X:YCH!I-([-E* AC"7J=V 69H
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M_XB3<]3J(AN&B4'8\:PPZ:O'")CO.;!OZWMP/D1714&< !HR)89S)5[NO=Z
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M!(U2)@DJ&J3YWS^5\&<JKER&8$&CLIH$@XR]@[(?A)A>6R!6LC\BBC$0 TZ
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MV2J*O,H6:T*FD#F??9;;%-_= #\$-S)$D<Z$"<]8/(.*M+]_@*[G%=JC5=M
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M-<Y"PS3M#"9CP93MA\I6(M&@=H7,NF_9VO.>Y3[_[I:_RM9RRKS)XLBG<&R
M5<9@NL[1?,F,#KP!IZWQS3IZ D7N!ACW4)=BH(\.H 1Y3'%,\LK%B<U!,?3(
MO<#H4;,@W.LQ1=QA+FX(BZ]K?XA7=DA=X?*8T(H::!$JYT-^]IW\0 *< 0'V
M 0$W@>813TY_)T \\!>0D\P!HCT'\W2YU9U<YAF:]%*D+@6<A>LJ4]%KML7)
MY878^0!FLXRXBQEG=5=K]"OLE/NULJ4%*-)AHC G&1[[MQX]N?/AGW1EKAF)
M#5YK5*?SY":XB3G)W#B3T?57,O')=1=G'>#:P33!K_"-ZQ>?7ER\:, OUU%
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MS2*ER;=.6[<M6B-!V)E(6&20S<50PM8&J8CB#/!Y/$O!'$E3<2KG-$.$D$T
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M5_HKW,[':_&@I/>269HI51<#E63!*$ _RUAFK+7#_\61-O046.+]3'1!;T_
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MF$]D=%R!$G:"B,,0=#XQ$<\RL!RE)KZYFA&*XRFGP0,U@!T>*MXIDM_U' -
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MQ#22.-))04,5PC(Q3H'FN$MYH)C=),AT^D>I:VRH  U!)A.[ =,D!LXU2S"
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ML.:GE@&_^2+5;97<?"$[]7JCL750/SC^T6+\<Z?6V&G4CO:.:GOU>GW-1A@
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ME2]?$E<VW&65!NK0H;WWL*L'AGB(5L;-E2__!W"9;N':@OL8B#["TUYK/%F
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MW\9(=]?'2$^W\3?ZP4/S>P#_!U!+ P04    " !E@JE8LR*%D6P%   &!@
M&0   &<X,#(T,39G,#4P.3$P,3@U-S(U,BYJ<&>=T7DTU L4!_#?;Q:SF(EA
M[%N6B:P9HY#)FV2BGE#/'NW2QE,Q@Z:%3,AR!HW29AU**LO84ID8*LD3P\S(
M2[8IO#)"0F\>G;?\TQ_OO>\]]Z][SSWG<ZY,*!L %+=0W:@ "(+ [J4"9'V
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M?>I#/<G A$E^LD,\VB3_[/?:22;Z U!+ 0(4 Q0    ( &6"J5C%J:3\/P,
M $P+   0              "  0    !C=G,M,C R-# U,#DN>'-D4$L! A0#
M%     @ 98*I6(,EK@5@!@  OD,  !0              ( !;0,  &-V<RTR
M,#(T,#4P.5]L86(N>&UL4$L! A0#%     @ 98*I6.@7.;:V!   ?2H  !0
M             ( !_PD  &-V<RTR,#(T,#4P.5]P<F4N>&UL4$L! A0#%
M  @ 98*I6'S<=B@W$0  #W@   X              ( !YPX  &0X,#(T,39D
M.&LN:'1M4$L! A0#%     @ 98*I6'Z\*E]E*   Y+T  !
M ( !2B   &0X,#(T,39D97@T,2YH=&U02P$"% ,4    " !E@JE8Y4I,8$TH
M  #BNP  $               @ '=2   9#@P,C0Q-F1E>#0R+FAT;5!+ 0(4
M Q0    ( &6"J5B#_KZ_9"@  .J\   0              "  5AQ  !D.# R
M-#$V9&5X-#,N:'1M4$L! A0#%     @ 98*I6*6#-]%&*   =KP  !
M         ( !ZID  &0X,#(T,39D97@T-"YH=&U02P$"% ,4    " !E@JE8
MIMM=2$\H  !JO   $               @ %>P@  9#@P,C0Q-F1E>#0U+FAT
M;5!+ 0(4 Q0    ( &6"J5C6?^VEAP\   Y0   0              "  =OJ
M  !D.# R-#$V9&5X-3$N:'1M4$L! A0#%     @ 98*I6+,BA9%L!0  !@8
M !D              ( !D/H  &<X,#(T,39G,#4P.3$P,3@U-S(U,BYJ<&=0
52P4&      L "P"Y @  ,P !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>d802416d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20240509.xsd" xlink:type="simple"/>
    <context id="duration_2024-05-09_to_2024-05-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2024-05-09</startDate>
            <endDate>2024-05-09</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-05-09_to_2024-05-09"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-334">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-05-09_to_2024-05-09"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-345">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-346">2024-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-347">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-348">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-349">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-350">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-351">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-352">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-353">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-354">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-355">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-356">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-357">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-358">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-359">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-360">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-361">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-362">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-05-09_to_2024-05-09" id="ixv-363">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
